- ¥391bn
- ¥582bn
- ¥812bn
Table: Kaneka - 9-MTH group results
Table: Kaneka - 6-MTH group results
Table: Kaneka -Q1 group results
Table: Kaneka -2020/21 group results
Table: Kaneka -2020/21 parent results
Table: Kaneka - 9-MTH group results
Inovio signs COVID-19 vaccine manufacturing deal with Japan's Kaneka
Inovio: Rises on manufacturing deal for COVID-19 vaccine candidate
Table: Kaneka - 6-MTH group results
Table: Kaneka -Q1 group results
Table: Kaneka -2019/20 parent results
Table: Kaneka -2019/20 group results
Japan to extend foreign investment controls to Avigan suppliers - Yomiuri
Brief: Kaneka Agrees With Fujifilm To Supply Active Pharmaceutical Ingredients For Anti-Flu Drug Avigan
Table: Kaneka - 9-MTH group results
Brief: Kaneka To Hold 86.61% In Ab-Biotics
Table: Kaneka - 6-MTH group results
Japan parental leave case puts spotlight on workers' rights
Brief: Kaneka To Hold 66.33% Of Ab-Biotics